Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-24, Stock:ABBV, The news for the past five days is as follows:
2019-01-16: NEWS1: Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings.NEWS2: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.NEWS3: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS4: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS5: Will Dividend Stocks be the Hot Stocks of 2019?.NEWS6: Noteworthy ETF Outflows: IUSG, NEE, ABBV, ISRG.NEWS7: Noteworthy ETF Outflows: IUSG, NEE, ABBV, ISRG.NEWS8: Merck or AbbVie: Which Company Returns More Value to Shareholders?.NEWS9: Katz:  Markets are looking past several negative headline....NEWS10: 3 of the Top Big Pharma Stocks to Buy Now.NEWS11: 3 of the Top Big Pharma Stocks to Buy Now.
2019-01-17: NEWS1: 1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet).NEWS2: 1 Chart That Shows Why Celgene Has Been Bought Out and Gilead Hasn't (Yet).NEWS3: Banks Keep Stocks Moving Higher.NEWS4: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS5: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS6: Trending: Investors Turn to Dividend Aristocrats Amid Market Volatility.NEWS7: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.NEWS8: 3 Healthcare Stocks That Will Keep Your Portfolio Healthy.
2019-01-18: NEWS1: AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study.NEWS2: AbbVie's cancer drug fails to meet main goal in late-stage study.NEWS3: AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer.NEWS4: These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts.NEWS5: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS6: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS7: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS8: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS9: AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth.NEWS10: Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?.NEWS11: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS12: Pacira's Study on Exparel Label Expansion Meets Endpoints.NEWS13: Are you a Tortoise or a Hare Investor?.NEWS14: Are you a Tortoise or a Hare Investor?.NEWS15: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS16: Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon.NEWS17: Are you a Tortoise or a Hare Investor?.NEWS18: Pacira's Study on Exparel Label Expansion Meets Endpoints.
2019-01-22: NEWS1: 5 Amazing Earnings Charts.NEWS2: 5 Amazing Earnings Charts.NEWS3: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS4: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS5: 5 Amazing Earnings Charts.NEWS6: J&J's (JNJ) Q4 Earnings Beat, 2019 Sales Forecast Soft.NEWS7: Bet on These 5 Low Leverage Stocks to Secure Returns.NEWS8: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS9: Better Buy: Pfizer vs. AbbVie.
2019-01-23: NEWS1: Top Research Reports for Amazon, Verizon & AbbVie.NEWS2: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS3: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.NEWS4: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS5: 3 Upcoming Readouts for Gilead Sciences You Don't Want to Miss.NEWS6: Is a Beat in Store for AbbVie (ABBV) This Earnings Season?.

Answer: Decrease